Abstract
The paper describes the design of, and the procedures used in a double blind randomized trial to determine whether the incidence of ischaemic heart disease can be lowered by the reduction of high and moderately high lipid levels in healthy men aged 30-59 years. The trial started in Edinburgh in 1965 and was extended to Prague and Budapest in 1966 and 1967. It is coordinated and controlled by a committee of investigators convened by the World Health Organization. The subjects were selected on the basis of a preliminary determination of serum cholesterol level. Half of the men in the upper third of the distribution of cholesterol values have been assigned at random to a treated group and take 1.6 g of clofibrate daily; the other half make up a control group and take identical capsules containing 300-350 mg of olive oil. A second control group, chosen at random from the lowest third of the cholesterol distribution, also receives the olive oil capsules. The study is designed to have a 90% chance of detecting, in the treated group, a reduction of one-third in the incidence of ischaemic heart disease if this should occur. The subjects are examined at the beginning of the trial, then at 6-month intervals for 2 years, and thereafter annually for at least 3 further years. The criteria of ischaemic heart disease are defined and the different control procedures are described. The required 15 000 subjects have now been admitted to the trial and their characteristics are described, but it is too early to report any results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLACKBURN H., KEYS A., SIMONSON E., RAUTAHARJU P., PUNSAR S. The electrocardiogram in population studies. A classification system. Circulation. 1960 Jun;21:1160–1175. doi: 10.1161/01.cir.21.6.1160. [DOI] [PubMed] [Google Scholar]
- Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
- Block W. D., Jarrett K. J., Jr, Levine J. B. An improved automated determination of serum total cholesterol with a single color reagent. Clin Chem. 1966 Oct;12(10):681–689. [PubMed] [Google Scholar]
- JURAND J., ALBERT-RECHT F. The estimation of serum cholesterol. Clin Chim Acta. 1962 Jul;7:522–528. doi: 10.1016/0009-8981(62)90093-1. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Dawber T. R., McNamara P. M. Detection of the coronary-prone adult: the Framingham study. J Iowa Med Soc. 1966 Jan;56(1):26–34. [PubMed] [Google Scholar]
- LEVINE J. B., ZAK B. AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL. Clin Chim Acta. 1964 Oct;10:381–384. doi: 10.1016/0009-8981(64)90073-7. [DOI] [PubMed] [Google Scholar]
- Morris J. N., Gardner M. J. Epidemiology of ischaemic heart disease. Am J Med. 1969 May;46(5):674–683. doi: 10.1016/0002-9343(69)90019-9. [DOI] [PubMed] [Google Scholar]
- OLIVER M. F. Reduction of serum-lipid and uric-acid levels by an orally active androsterone. Lancet. 1962 Jun 23;1(7243):1321–1323. doi: 10.1016/s0140-6736(62)92422-4. [DOI] [PubMed] [Google Scholar]
- Oliver M. F. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate). Bull N Y Acad Med. 1968 Aug;44(8):1021–1027. [PMC free article] [PubMed] [Google Scholar]
- THORP J. M., WARING W. S. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature. 1962 Jun 9;194:948–949. doi: 10.1038/194948a0. [DOI] [PubMed] [Google Scholar]
- THROP J. M. Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate. Lancet. 1962 Jun 23;1(7243):1323–1326. doi: 10.1016/s0140-6736(62)92423-6. [DOI] [PubMed] [Google Scholar]